These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 26186905)
1. Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective. Mathew G; Unnikrishnan MK Inflamm Res; 2015 Oct; 64(10):747-52. PubMed ID: 26186905 [TBL] [Abstract][Full Text] [Related]
2. A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target. Gejjalagere Honnappa C; Mazhuvancherry Kesavan U Int J Immunopathol Pharmacol; 2016 Dec; 29(4):562-571. PubMed ID: 27707958 [TBL] [Abstract][Full Text] [Related]
3. Multi-target approach for natural products in inflammation. Koeberle A; Werz O Drug Discov Today; 2014 Dec; 19(12):1871-82. PubMed ID: 25172801 [TBL] [Abstract][Full Text] [Related]
4. Naturally derived anti-inflammatory compounds from Chinese medicinal plants. Wang Q; Kuang H; Su Y; Sun Y; Feng J; Guo R; Chan K J Ethnopharmacol; 2013 Mar; 146(1):9-39. PubMed ID: 23274744 [TBL] [Abstract][Full Text] [Related]
5. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. Perretti M; Leroy X; Bland EJ; Montero-Melendez T Trends Pharmacol Sci; 2015 Nov; 36(11):737-755. PubMed ID: 26478210 [TBL] [Abstract][Full Text] [Related]
7. Proximal signaling molecules as potential targets for anti-inflammatory therapy. Löwenberg M Curr Opin Drug Discov Devel; 2007 Sep; 10(5):560-4. PubMed ID: 17786854 [TBL] [Abstract][Full Text] [Related]
8. The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders. Antonioli L; Colucci R; Pellegrini C; Giustarini G; Sacco D; Tirotta E; Caputi V; Marsilio I; Giron MC; Németh ZH; Blandizzi C; Fornai M Expert Opin Ther Targets; 2016; 20(2):179-91. PubMed ID: 26414111 [TBL] [Abstract][Full Text] [Related]
9. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective. Zhang W; Bai Y; Wang Y; Xiao W Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941 [TBL] [Abstract][Full Text] [Related]
10. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation. Bai R; Yao C; Zhong Z; Ge J; Bai Z; Ye X; Xie T; Xie Y Eur J Med Chem; 2021 Mar; 213():113165. PubMed ID: 33454546 [TBL] [Abstract][Full Text] [Related]
11. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Kaminska B Biochim Biophys Acta; 2005 Dec; 1754(1-2):253-62. PubMed ID: 16198162 [TBL] [Abstract][Full Text] [Related]
12. Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis. Li B; Li W; Li X; Zhou H Curr Pharm Des; 2017; 23(8):1216-1227. PubMed ID: 28034355 [TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligases as novel targets for inflammatory diseases. Goru SK; Pandey A; Gaikwad AB Pharmacol Res; 2016 Apr; 106():1-9. PubMed ID: 26875639 [TBL] [Abstract][Full Text] [Related]
14. Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery. Li J; Zhao R; Miao P; Xu F; Chen J; Jiang X; Hui Z; Wang L; Bai R Eur J Med Chem; 2023 Nov; 260():115791. PubMed ID: 37683361 [TBL] [Abstract][Full Text] [Related]
15. Two faces of inflammation: an immunopharmacological view. Moilanen E Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):2-6. PubMed ID: 24286361 [TBL] [Abstract][Full Text] [Related]
17. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glucoside exerts anti-inflammatory effects on lipopolysaccharide-stimulated microglia by inhibiting NF-κB and activating AMPK/Nrf2 pathways. Park SY; Jin ML; Wang Z; Park G; Choi YW Food Chem Toxicol; 2016 Nov; 97():159-167. PubMed ID: 27621050 [TBL] [Abstract][Full Text] [Related]
18. Impact of 5-HT₃ receptor antagonists on peripheral and central diseases. Fakhfouri G; Rahimian R; Ghia JE; Khan WI; Dehpour AR Drug Discov Today; 2012 Jul; 17(13-14):741-7. PubMed ID: 22390946 [TBL] [Abstract][Full Text] [Related]
19. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344 [TBL] [Abstract][Full Text] [Related]